Strong Market Debut for Fusion Pioneer
General Fusion officially began trading on the Nasdaq stock exchange on Monday under the ticker symbol GFUZ, marking a significant milestone as the first publicly listed fusion power company. The Canadian firm edged out competitor TAE Technologies, which has received backing from the Trump administration, by several months in reaching the public markets.
Investors showed strong appetite for the newly public company. Shares rallied as trading opened and climbed approximately 40% from the initial price of $12.85 by early afternoon.
The public listing follows the completion of a reverse merger with Spring Valley Acquisition Corp. III, a special purpose acquisition company. General Fusion first announced the merger agreement in January, and the transaction was finalized last week.
Funding Challenges Preceded the SPAC Deal
While the merger could have added as much as $230 million to General Fusion's balance sheet without shareholder redemptions, the reality proved more modest. Most de-SPAC transactions experience significant redemptions before completion, and this deal was no exception. Although the company has not disclosed the exact redemption figure, a report in the Globe and Mail estimated that General Fusion may receive less than $30 million after redemptions and associated fees.
Separately from the de-SPAC transaction, General Fusion secured $108 million from private investors. In total, the company reports holding approximately $150 million in cash.
The path to going public was driven by financial necessity. Before the reverse merger was announced, General Fusion was running low on cash and facing difficulties raising additional capital. The company had reportedly been seeking to raise $125 million, but by May 2025, that funding had not materialized, prompting the layoff of at least 25% of its workforce.
Three months after those layoffs, General Fusion persuaded existing investors to contribute an additional $22 million in what was described as a "pay to play" funding round. That infusion provided temporary relief, but the high costs associated with fusion energy development soon sent the company searching for more substantial funding, ultimately leading to the reverse merger.
